Companies / United Immunity
United Immunity
Japan
United Immunity develops next-generation in vivo cell therapies using its Myeloid Targeting Platform technology to selectively target and program immune cells in the body for the treatment of various diseases.
United Immunity, based in Japan, has 7 investors on file, among them Axil Capital, Kobe University Capital and Miyako Capital. Its latest round on record is Series A, 24 Sept 2026. Its site was last checked 13 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
7 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Page + round | Venture capital | |
| Page + round | Corporate VC | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get United Immunity and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Axil Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/unitedimmunity.co.jp/investors
# also
GET /v1/companies/unitedimmunity.co.jp
GET /v1/companies/unitedimmunity.co.jp/news